Jens Tijtgat

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

Johnny Duerinck, Julia Katharina Schwarze, Gil Awada et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

Gil Awada, Yanina Jansen, Julia Katharina Schwarze et al. · Cancers · 2021 · 35 citations · Full text

Intratumoral administration of CD1c (BDCA-1)⁺ and CD141 (BDCA-3)⁺ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial

Julia Katharina Schwarze, Jens Tijtgat, Gil Awada et al. · Journal for ImmunoTherapy of Cancer · 2022 · 33 citations · Full text

Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial

Julia Katharina Schwarze, Gil Awada, Louise Cras et al. · Vaccines · 2020 · 27 citations · Full text

Sexual violence in medical students and specialty registrars in Flanders, Belgium: a population survey

M. Geldolf, Jens Tijtgat, L Dewulf et al. · BMC Medical Education · 2021 · 17 citations · Full text